These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9788735)

  • 1. The Met54Leu polymorphism of paraoxonase (PON) enzyme gene is not a genetic risk factor for non-insulin-dependent diabetes mellitus in Finns.
    Malin R; Huang XH; Wirta O; Rantalaiho V; Pasternack A; Jokela H; Koivula T; Lehtimäki T
    Clin Genet; 1998 Sep; 54(3):254-5. PubMed ID: 9788735
    [No Abstract]   [Full Text] [Related]  

  • 2. Promoter polymorphism T(-107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic patients.
    James RW; Leviev I; Ruiz J; Passa P; Froguel P; Garin MC
    Diabetes; 2000 Aug; 49(8):1390-3. PubMed ID: 10923642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum paraoxonase activity and paraoxonase gene polymorphism in type 2 diabetic patients with or without vascular complications.
    Letellier C; Durou MR; Jouanolle AM; Le Gall JY; Poirier JY; Ruelland A
    Diabetes Metab; 2002 Sep; 28(4 Pt 1):297-304. PubMed ID: 12442067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum paraoxonase activity and genotype distribution in Japanese patients with diabetes mellitus.
    Sakai T; Matsuura B; Onji M
    Intern Med; 1998 Jul; 37(7):581-4. PubMed ID: 9711883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between M/L55-polymorphism of paraoxonase enzyme and oxidative DNA damage in patients with type 2 diabetes mellitus and in control subjects.
    Malin R; Rantalaiho V; Huang XH; Wirta O; Pasternack A; Leinonen JS; Alho H; Jokela H; Koivula T; Tanaka T; Okada K; Ochi H; Toyokuni S; Lehtimäki T
    Hum Genet; 1999; 105(1-2):179-80. PubMed ID: 10480377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association between carotid intima-media thickness and paraoxonase gene polymorphism in non-insulin dependent diabetes mellitus.
    Cao H; Girard-Globa A; Serusclat A; Bernard S; Bondon P; Picard S; Berthezene F; Moulin P
    Atherosclerosis; 1998 Jun; 138(2):361-6. PubMed ID: 9690920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum paraoxonase activity and its relationship to diabetic complications in patients with non-insulin-dependent diabetes mellitus.
    Ikeda Y; Suehiro T; Inoue M; Nakauchi Y; Morita T; Arii K; Ito H; Kumon Y; Hashimoto K
    Metabolism; 1998 May; 47(5):598-602. PubMed ID: 9591753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes.
    Pfohl M; Koch M; Enderle MD; Kühn R; Füllhase J; Karsch KR; Häring HU
    Diabetes; 1999 Mar; 48(3):623-7. PubMed ID: 10078566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraoxonase 55 and 192 polymorphism and its relationship to serum paraoxonase activity and serum lipids in Turkish patients with non-insulin dependent diabetes mellitus.
    Agachan B; Yilmaz H; Karaali Z; Isbir T
    Cell Biochem Funct; 2004; 22(3):163-8. PubMed ID: 15124181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM Study.
    Herrmann SM; Blanc H; Poirier O; Arveiler D; Luc G; Evans A; Marques-Vidal P; Bard JM; Cambien F
    Atherosclerosis; 1996 Oct; 126(2):299-303. PubMed ID: 8902155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraoxonase 1 192 Gln/Arg gene polymorphism and cerebrovascular disease: interaction with type 2 diabetes.
    Koch M; Hering S; Barth C; Ehren M; Enderle MD; Pfohl M
    Exp Clin Endocrinol Diabetes; 2001; 109(3):141-5. PubMed ID: 11409295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.
    Garin MC; James RW; Dussoix P; Blanché H; Passa P; Froguel P; Ruiz J
    J Clin Invest; 1997 Jan; 99(1):62-6. PubMed ID: 9011577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy.
    Mackness B; Durrington PN; Abuashia B; Boulton AJ; Mackness MI
    Clin Sci (Lond); 2000 Mar; 98(3):355-63. PubMed ID: 10677395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary artery disease risk in Chinese type 2 diabetics: is there a role for paraxonase 1 gene (Q192R) polymorphism?
    Osei-Hyiaman D; Hou L; Mengbai F; Zhiyin R; Zhiming Z; Kano K
    Eur J Endocrinol; 2001 Jun; 144(6):639-44. PubMed ID: 11375798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraoxonase producing PON1 gene M/L55 polymorphism is related to autopsy-verified artery-wall atherosclerosis.
    Malin R; Järvinen O; Sisto T; Koivula T; Lehtimäki T
    Atherosclerosis; 2001 Aug; 157(2):301-7. PubMed ID: 11472729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraoxonase (Gln192-Arg) polymorphism in French type 2 diabetics.
    Helbecque N; Cottel D; Meirhaeghe A; Dallongeville J; Amouyel P
    Atherosclerosis; 1999 Dec; 147(2):415-6. PubMed ID: 10627268
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus.
    Mackness B; Mackness MI; Arrol S; Turkie W; Julier K; Abuasha B; Miller JE; Boulton AJ; Durrington PN
    Atherosclerosis; 1998 Aug; 139(2):341-9. PubMed ID: 9712341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes.
    Ruiz J; Blanché H; James RW; Garin MC; Vaisse C; Charpentier G; Cohen N; Morabia A; Passa P; Froguel P
    Lancet; 1995 Sep; 346(8979):869-72. PubMed ID: 7564671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns.
    Antikainen M; Murtomäki S; Syvänne M; Pahlman R; Tahvanainen E; Jauhiainen M; Frick MH; Ehnholm C
    J Clin Invest; 1996 Aug; 98(4):883-5. PubMed ID: 8770857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No association of paraoxonase gene polymorphism with atherosclerosis or Alzheimer's disease.
    Sodeyama N; Yamada M; Itoh Y; Suematsu N; Matsushita M; Otomo E; Mizusawa H
    Neurology; 1999 Sep; 53(5):1146-8. PubMed ID: 10496287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.